TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00597623 — Safety Biomarker (SAF): Interleukin 1
Study NCT01456104 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study NCT01456104 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01456104 — Predictive Biomarker (PRD): TDO2 mRNA
Genes: TDO2; TDO
Study NCT00622479 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00622479 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT00369551 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01651065 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03603444 — Surrogate Endpoint (SUR): Serum calcium
Study NCT03603444 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT03603444 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03406715 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT00910728 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT02401880 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04677608 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04677608 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT04677608 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT03006081 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04645407 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04645407 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05218018 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT03929861 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02155647 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT00281684 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT04449276 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01861548 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02467569 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04780854 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT04648618 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04126603 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04029623 — Predictive Biomarker (PRD): ASPSCR1 mRNA
Genes: ASPSCR1; ASPL; RCC17; TUG; UBXD9; UBXN9
Study NCT02556671 — Predictive Biomarker (PRD): VASP mRNA
Genes: VASP
Study NCT02658981 — Predictive Biomarker (PRD): TNFRSF9 mRNA
Genes: TNFRSF9; CD137; ILA
Study NCT02832518 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03260374 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study NCT03168555 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 19
Genes: FGF19; UNQ334/PRO533
Study NCT03797508 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT01053403 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT04408170 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00660075 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00660075 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01082588 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00490867 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00204412 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01630941 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04381572 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00273299 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02134067 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study NCT01090869 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02065076 — Surrogate Endpoint (SUR): Serum potassium
Study NCT03815812 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03608046 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03608046 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT02450500 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01006213 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01001572 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02546310 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT04062370 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01242254 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02967484 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03666273 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ILDR2 mRNA
Genes: ILDR2; C1orf32
Study NCT03810521 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04302987 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01976169 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03380507 — Predictive Biomarker (PRD): SLC23A2 mRNA
Genes: SLC23A2; KIAA0238; NBTL1; SLC23A1; SVCT2; YSPL2
Study NCT03924648 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT02333669 — Predictive Biomarker (PRD): SCNN1A mRNA
Genes: SCNN1A; SCNN1
Study NCT00361218 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT00361218 — Safety Biomarker (SAF): BDNF
Study NCT01425853 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT04110184 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT00083629 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT00004041 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT00004041 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT04916756 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT04916756 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT04916756 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study NCT04916756 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01190072 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT04140539 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT04494958 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT00103597 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03767998 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT02055170 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT03777085 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT02323399 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02841917 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT01277913 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01277913 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02104323 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study NCT04356209 — Predictive Biomarker (PRD): RHOF mRNA
Genes: RHOF; ARHF; RIF
Study NCT04356209 — Predictive Biomarker (PRD): CCN2 mRNA
Genes: CCN2; CTGF; HCS24; IGFBP8
Study NCT01204307 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01495364 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00589316 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT03326583 — Surrogate Endpoint (SUR): Serum potassium
Study NCT02648243 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04277663 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT02709109 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT03769337 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT03769337 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study NCT01412151 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT00259246 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT01891799 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02954445 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04298931 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00323024 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00825149 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT01277978 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04518345 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT01930240 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01997281 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT01150058 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT03114098 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT00805012 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT04657445 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04446624 — Monitoring Biomarker (MOI): IL4 mRNA
Genes: IL4
Study NCT04446624 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04446624 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04446624 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04446624 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00644124 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03123484 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03123484 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04415190 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT00677560 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT02511275 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study NCT02511275 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT02511275 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT01079195 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00047008 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02923648 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study NCT01660230 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT01176240 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02274415 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00423592 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01041404 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00567957 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02439736 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT02989441 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02152449 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT02011672 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02608372 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT00001540 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01686412 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01553045 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT00178698 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study NCT01543113 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT01543113 — Predictive Biomarker (PRD): KIT
Genes: CD117; SCFR; C-Kit
Study NCT00636441 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00838370 — Safety Biomarker (SAF): Dihydrothymine dehydrogenase
Genes: DPYD
Study NCT00092404 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT02178306 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02339142 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT01917240 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study NCT03314012 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03125993 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT00882336 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02979444 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT02574390 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT01495078 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02468141 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT02468141 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02215616 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT03926260 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03926260 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03926260 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT03926260 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03926260 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03926260 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04834050 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01983618 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00973180 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00973180 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00247273 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02744560 — Predictive Biomarker (PRD): Liver iron
Study NCT01894334 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03997760 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study NCT00396825 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01609725 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01577004 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT04142710 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04134299 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT02525887 — Predictive Biomarker (PRD): VKORC1 mRNA
Genes: VKORC1; VKOR; MSTP134; MSTP576; UNQ308/PRO351
Study NCT02324738 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT04447118 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03807778 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03807778 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04451226 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02965937 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00961298 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT04122586 — Predictive Biomarker (PRD): EIF2AK3 mRNA
Genes: EIF2AK3; PEK; PERK
Study NCT02529670 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00297128 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01531361 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT01531361 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT01531361 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT01531361 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT01531361 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01531361 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT01728727 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03006796 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03261570 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01191281 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03857607 — Predictive Biomarker (PRD): ATP1A3 mRNA
Genes: ATP1A3
Study NCT05022043 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT05022043 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04366713 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02639923 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT02639923 — Safety Biomarker (SAF): miR-16
Study NCT00441480 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00138229 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT00138229 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02919410 — Surrogate Endpoint (SUR): Bacterial count
Study NCT03770780 — Predictive Biomarker (PRD): SAGE1 mRNA
Genes: SAGE1; SAGE
Study NCT01489267 — Predictive Biomarker (PRD): ATXN1 mRNA
Genes: ATXN1; ATX1; SCA1
Study NCT01302691 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02177812 — Predictive Biomarker (PRD): KDM1A mRNA
Genes: KDM1A; AOF2; KDM1; KIAA0601; LSD1
Study NCT03938012 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT03938012 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT03938012 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT02920450 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01921452 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT02822157 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT01756430 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01112982 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00927758 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT03080051 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT01627223 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00003408 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03251872 — Predictive Biomarker (PRD): PARP1 mRNA
Genes: PARP1; ADPRT; PPOL
Study NCT00126672 — Predictive Biomarker (PRD): TSC2
Genes: tuberin; LAM; PPP1R160
Study NCT01600794 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT02732223 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04083794 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01386567 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT02540876 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study NCT00228189 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT01847079 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT04227210 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00212758 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03381625 — Predictive Biomarker (PRD): BMX mRNA
Genes: BMX
Study NCT01582958 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT00722098 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00722098 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT00801346 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03550365 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03550365 — Safety Biomarker (SAF): Interleukin 1
Study NCT04367311 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04016987 — Surrogate Endpoint (SUR): Serum hemoglobin A1C
Study NCT00901589 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01819441 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01819441 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00005061 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02537223 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT02537223 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02597192 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT03628066 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03628066 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02579902 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03385525 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT02896192 — Predictive Biomarker (PRD): POMC mRNA
Genes: POMC
Study NCT02896192 — Predictive Biomarker (PRD): PCSK1 mRNA
Genes: PCSK1; NEC1
Study NCT03290794 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05906667 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03709511 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT00318370 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT05655650 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL